These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 6440788)
1. Dose-dependent change in tissue uptake of 17 beta-(16 alpha-[125I]iodo)-estradiol in female rats: application to external imaging of mammary carcinoma. Noguchi S; Koyama H; Nakano S Eur J Nucl Med; 1984; 9(11):490-3. PubMed ID: 6440788 [TBL] [Abstract][Full Text] [Related]
2. Characterization of the uptake of 16 alpha-([18F]fluoro)-17 beta-estradiol in DMBA-induced mammary tumors. Mathias CJ; Welch MJ; Katzenellenbogen JA; Brodack JW; Kilbourn MR; Carlson KE; Kiesewetter DO Int J Rad Appl Instrum B; 1987; 14(1):15-25. PubMed ID: 3108199 [TBL] [Abstract][Full Text] [Related]
3. Radioiodinated ligands for the estrogen receptor: tissue distribution of 17 alpha-[125I]iodovinylestradiol derivatives in normal and tumor-bearing adult female rats. Hanson RN; Franke LA; Kaplan M Int J Rad Appl Instrum B; 1990; 17(2):239-45. PubMed ID: 2111297 [TBL] [Abstract][Full Text] [Related]
4. Antitumor effects of droloxifene, a new antiestrogen drug, against 7,12-dimethylbenz(a)anthracene-induced mammary tumors in rats. Kawamura I; Mizota T; Kondo N; Shimomura K; Kohsaka M Jpn J Pharmacol; 1991 Oct; 57(2):215-24. PubMed ID: 1812300 [TBL] [Abstract][Full Text] [Related]
5. Biodistribution and breast tumor uptake of 16alpha-[18F]-fluoro-17beta-estradiol in rat. Sasaki M; Fukumura T; Kuwabara Y; Yoshida T; Nakagawa M; Ichiya Y; Masuda K Ann Nucl Med; 2000 Apr; 14(2):127-30. PubMed ID: 10830531 [TBL] [Abstract][Full Text] [Related]
7. Estrogen receptor binding radiopharmaceuticals: II. Tissue distribution of 17 alpha-methylestradiol in normal and tumor-bearing rats. Feenstra A; Vaalburg W; Nolten GM; Reiffers S; Talma AG; Wiegman T; van der Molen HD; Woldring MG J Nucl Med; 1983 Jun; 24(6):522-8. PubMed ID: 6406650 [TBL] [Abstract][Full Text] [Related]
8. Receptor-binding radiopharmaceuticals for imaging breast tumors: estrogen-receptor interactions and selectivity of tissue uptake of halogenated estrogen analogs. Katzenellenbogen JA; Carlson KE; Heiman DF; Goswami R J Nucl Med; 1980 Jun; 21(6):550-8. PubMed ID: 6247466 [TBL] [Abstract][Full Text] [Related]
9. New iodinated progestins as potential ligands for progesterone receptor imaging in breast cancer. Part 2: In vivo pharmacological characterization. Rijks LJ; van den Bos JC; van Doremalen PA; Boer GJ; de Bruin K; Janssen AG; van Royen EA Nucl Med Biol; 1998 Nov; 25(8):791-8. PubMed ID: 9863568 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and pharmacokinetics of 131I labeled benzoyl derivatives of estrone and estradiol. Brandau W; Eisenhut M; Taylor DM Int J Appl Radiat Isot; 1985 May; 36(5):379-84. PubMed ID: 3926658 [TBL] [Abstract][Full Text] [Related]
11. 16 alpha-[77Br]bromoestradiol-17 beta: a high specific-activity, gamma-emitting tracer with uptake in rat uterus and uterus and induced mammary tumors. Katzenellenbogen JA; Senderoff SG; McElvany KD; O'Brien HA; Welch MJ J Nucl Med; 1981 Jan; 22(1):42-7. PubMed ID: 6778976 [TBL] [Abstract][Full Text] [Related]
12. Synthesis, estrogen receptor binding, and tissue distribution of a new iodovinylestradiol derivative (17alpha,20E)-21-[123I]Iodo-11beta-nitrato-19-norp regna-1,3,5 (10),20-tetraene-3,17-diol (E-[123I]NIVE). Rijks LJ; van den Bos JC; van Doremalen PA; Boer GJ; de Bruin K; Doornbos T; Vekemans JA; Posthumus MA; Janssen AG; van Royen EA Nucl Med Biol; 1998 May; 25(4):411-21. PubMed ID: 9639304 [TBL] [Abstract][Full Text] [Related]
13. Mammary tumor immunoscintigraphy in rats: the use of 131I-anti-estriol 3-sulfate antibody. Shimura N; Komori Y; Tanaka T; Kubodera A; Oyamada H Int J Rad Appl Instrum B; 1990; 17(6):553-60. PubMed ID: 2123840 [TBL] [Abstract][Full Text] [Related]
14. The synthesis of 11 beta-methoxy-[16 alpha-123I] iodoestradiol and its interaction with the estrogen receptor in vivo and in vitro. Zielinski JE; Larner JM; Hoffer PB; Hochberg RB J Nucl Med; 1989 Feb; 30(2):209-15. PubMed ID: 2738649 [TBL] [Abstract][Full Text] [Related]
15. Biologic activity of the iodoestrogens and their use in breast cancer. Longcope C; Arunachalam T; Rafkind I; Caspi E Adv Exp Med Biol; 1981; 138():191-210. PubMed ID: 7342716 [TBL] [Abstract][Full Text] [Related]
16. Influence of prenatal exposure to diethylstilbestrol on estrogen and progestin binding proteins in uteri and dimethylbenzanthracene- induced mammary tumors of the rat. Heidemann PH; Wittliff JL; Calhoon RE; Boylan ES J Toxicol Environ Health; 1981 Oct; 8(4):667-86. PubMed ID: 6802985 [TBL] [Abstract][Full Text] [Related]
17. Organ distribution and autoradiography after administration of 125I-16 alpha-iodo-estradiol in female rats. Holan J; Hutka Z; Stranská M; Palencárová M; Belej K; Misíková R; Levcík A; Altmann P; Putz Z Endocrinol Exp; 1985 Dec; 19(4):297-303. PubMed ID: 3878781 [TBL] [Abstract][Full Text] [Related]
18. Potent inhibitory effect of a new antiestrogen (RU 16117) on the growth of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors. Kelly PA; Asselin J; Caron MG; Labrie F; Raynaud JP J Natl Cancer Inst; 1977 Mar; 58(3):623-8. PubMed ID: 402479 [TBL] [Abstract][Full Text] [Related]
19. 17 alpha-Z-[125I]iodovinyloestradiol and its 3-acetate: chemical synthesis in vivo distribution studies in the rat. Comparison of tissue accumulation and metabolic stability with 17 alpha-E-[125I]iodovinyl and 16 alpha-[125I]iodo oestradiols. Symes EK; Bishop PB; Coulson WF; Davies AG Biochem Pharmacol; 1992 Aug; 44(4):741-6. PubMed ID: 1510721 [TBL] [Abstract][Full Text] [Related]